UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

The New England journal of medicine, 2021-01, Vol.384 (3), p.229-237

2021

Volltextzugriff (PDF)

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-02, Vol.325 (7), p.632

2021

Volltextzugriff (PDF)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

The New England journal of medicine, 2021-10, Vol.385 (15), p.1382-1392

2021

Volltextzugriff (PDF)

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial

JAMA neurology, 2022-12, Vol.79 (12), p.1250

2022

Volltextzugriff (PDF)

The Cancer Immunotherapy Biomarker Testing Landscape

Archives of pathology & laboratory medicine (1976), 2020-06, Vol.144 (6), p.706-724

2020

Volltextzugriff (PDF)

Considerations in the development of circulating tumor cell technology for clinical use

Journal of translational medicine, 2012-07, Vol.10 (1), p.138-138, Article 138

2012

Volltextzugriff (PDF)

A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.460-467

2020

Volltextzugriff (PDF)

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

Blood, 2008-02, Vol.111 (3), p.1366-1377

2008

Volltextzugriff (PDF)

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

PloS one, 2013-11, Vol.8 (11), p.e80292-e80292

2013

Volltextzugriff (PDF)

Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections

Laboratory investigation, 2023-04, Vol.103 (4), p.100052-100052, Article 100052

2023

Volltextzugriff (PDF)

Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score and dietary intervention response

Diagnostic pathology, 2023-11, Vol.18 (1), p.1-122, Article 122

2023

Volltextzugriff (PDF)

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

Scientific reports, 2020-06, Vol.10 (1), p.9805-9805, Article 9805

2020

Volltextzugriff (PDF)

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

Cancer cell international, 2017-05, Vol.17 (1), p.56-56, Article 56

2017

Volltextzugriff (PDF)

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

Laboratory investigation, 2020-06, Vol.100 (6), p.874-886

2020

Volltextzugriff (PDF)

Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration

Clinical chemistry (Baltimore, Md.), 2012-08, Vol.58 (8), p.1225-1232

2012

Volltextzugriff (PDF)

Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization

Archives of pathology & laboratory medicine (1976), 2022-03, Vol.146 (3), p.351-359

2022

Volltextzugriff (PDF)

Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays

The journal of histochemistry and cytochemistry, 2016-12, Vol.64 (12), p.785-810

2016

Volltextzugriff (PDF)

Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory

Archives of pathology & laboratory medicine (1976), 2015-10, Vol.139 (10), p.1201-1201

2015

Volltextzugriff (PDF)

Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma

Anticancer research, 2016-06, Vol.36 (6), p.2683-2696

2016

Volltextzugriff (PDF)

Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma

Anticancer research, 2016-07, Vol.36 (7), p.3277-3288

2016

Volltextzugriff (PDF)

Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis

Blood, 2006-06, Vol.107 (12), p.4834-4840

2006

Volltextzugriff (PDF)

Lipid Raft Heterogeneity in Human Peripheral Blood T Lymphoblasts: A Mechanism for Regulating the Initiation of TCR Signal Transduction

The Journal of immunology (1950), 2002-03, Vol.168 (5), p.2233-2239

2002

Volltextzugriff (PDF)

Ischemic Time Impacts Biological Integrity of Phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK Signaling Networks

Anticancer research, 2011-06, Vol.31 (6), p.2073-2081

2011

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(136)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(155)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

The Cancer Immunotherapy Biomarker Testing Landscape

Considerations in the development of circulating tumor cell technology for clinical use

A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung

Targeted Quantitative Mass Spectrometry Analysis of Protein Biomarkers From Previously Stained Single Formalin-Fixed Paraffin-Embedded Tissue Sections

Pathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score and dietary intervention response

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration

Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization

Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays

Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory

Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma

Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma

Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis

Lipid Raft Heterogeneity in Human Peripheral Blood T Lymphoblasts: A Mechanism for Regulating the Initiation of TCR Signal Transduction

Ischemic Time Impacts Biological Integrity of Phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK Signaling Networks

Suchergebnisse filtern